Development of Left Ventricular Hypertrophy in Treated Hypertensive Outpatients

Hypertension

Volumn 69, Issue 1, 2017, Pages 136-142

  Izzo, Raffaele ^a,b   Losi, Maria Angela ^a,c   Stabile, Eugenio ^a,c   Lönnebakken, Mai Tone ^d   Canciello, Grazia ^a,c   Esposito, Giovanni ^a,c   Barbato, Emanuele ^a,c   De Luca, Nicola ^a,c   Trimarco, Bruno ^a,c   De Simone, Giovanni ^a,c  

^a FEDERICO II UNIVERSITY HOSPITAL   (Italy)

^b Department of Translational Medical Sciences ^*  (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d UNIVERSITY OF BERGEN   (Norway)

Author keywords

blood pressure; echocardiography; female; hypertension; obesity

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOSE; ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTERIAL WALL THICKNESS; ARTICLE; COHORT ANALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; GROUPS BY AGE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OBESITY; OUTPATIENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; BLOOD PRESSURE; CLINICAL TRIAL; COMPLICATION; CONTROLLED STUDY; DIAGNOSTIC IMAGING; HEART VENTRICLE; HYPERTROPHY, LEFT VENTRICULAR; INCIDENCE; ITALY; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; TIME FACTOR;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART VENTRICLES; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; INCIDENCE; ITALY; MALE; MIDDLE AGED; OUTPATIENTS; PREVALENCE; TIME FACTORS;

EID: 85000405989     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.116.08158     Document Type: Article

References (41)

1. de Simone G, Izzo R, Chinali M, De Marco M, Casalnuovo G, Rozza F, Girfoglio D, Iovino GL, Trimarco B, De Luca N. Does information on systolic and diastolic function improve prediction of a cardiovascular event by left ventricular hypertrophy in arterial hypertension? Hypertension. 2010;56:99-104. doi: 10.1161/HYPERTENSIONAHA.110.150128.
2. Izzo R, de Simone G, Devereux RB, Giudice R, De Marco M, Cimmino CS, Vasta A, De Luca N, Trimarco B. Initial left-ventricular mass predicts probability of uncontrolled blood pressure in arterial hypertension. J Hypertens. 2011;29:803-808. doi: 10.1097/HJH.0b013e328343ce32.
3. Devereux RB, Wachtell K, Gerdts E, Boman K, Nieminen MS, Papademetriou V, Rokkedal J, Harris K, Aurup P, Dahlöf B. Prognostic significance of left ventricular mass change during treatment of hypertension. JAMA. 2004;292:2350-2356. doi: 10.1001/jama.292.19.2350.
4. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990;322:1561-1566. doi: 10.1056/NEJM199005313222203.
5. Lembo G, Morisco C, Lanni F, Barbato E, Vecchione C, Fratta L, Trimarco B. Systemic hypertension and coronary artery disease: the link. Am J Cardiol. 1998;82(3A):2H-7H.
6. Izzo R, de Simone G, Trimarco V, Gerdts E, Giudice R, Vaccaro O, De Luca N, Trimarco B. Hypertensive target organ damage predicts incident diabetes mellitus. Eur Heart J. 2013;34:3419-3426. doi: 10.1093/ eurheartj/eht281.
7. Mancia G, Fagard R, Narkiewicz K, et al; Task Force Members. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31:1281-1357. doi: 10.1097/01. hjh.0000431740.32696.cc.
8. James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311:507-520. doi: 10.1001/jama.2013.284427.
9. Fagard RH, Celis H, Thijs L, Wouters S. Regression of left ventricular mass by antihypertensive treatment: a meta-analysis of randomized comparative studies. Hypertension. 2009;54:1084-1091. doi: 10.1161/ HYPERTENSIONAHA.109.136655.
10. Izzo R, Stabile E, Esposito G, Trimarco V, Laurino FI, Rao MA, De Marco M, Losi MA, De Luca N, Trimarco B, de Simone G. Development of new atherosclerotic plaque in hypertensive patients: an observational registry study from the Campania-Salute network. J Hypertens. 2015;33:2471-2476. doi: 10.1097/HJH.0000000000000740.
11. De Luca N, Izzo R, Iaccarino G, Malini PL, Morisco C, Rozza F, Iovino GL, Rao MA, Bodenizza C, Lanni F, Guerrera L, Arcucci O, Trimarco B. The use of a telematic connection for the follow-up of hypertensive patients improves the cardiovascular prognosis. J Hypertens. 2005;23:1417-1423. doi: 10.1097/01.hjh.0000173526.65555.55.
12. de Simone G, Izzo R, Aurigemma GP, De Marco M, Rozza F, Trimarco V, Stabile E, De Luca N, Trimarco B. Cardiovascular risk in relation to a new classification of hypertensive left ventricular geometric abnormalities. J Hypertens. 2015;33:745-754; discussion 754. doi: 10.1097/ HJH.0000000000000477.
13. Losi MA, Izzo R, De Marco M, Canciello G, Rapacciuolo A, Trimarco V, Stabile E, Rozza F, Esposito G, De Luca N, de Simone G, Trimarco B. Cardiovascular ultrasound exploration contributes to predict incident atrial fibrillation in arterial hypertension: the Campania Salute Network. Int J Cardiol. 2015;199:290-295. doi: 10.1016/j.ijcard.2015.07.019.
14. Izzo R, Stabile E, Esposito G, Trimarco V, De Marco M, Sica A, Manzi MV, Gargiulo G, Schiattarella G, Rozza F, De Luca N, de Simone G. Prevalence and characteristics of true and apparent treatment resistant hypertension in the Campania Salute Network. Int J Cardiol. 2015;184:417-419. doi: 10.1016/j.ijcard.2015.03.022.
15. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF III, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604-612. doi: 10.7326/0003-4819-150-9-200905050-00006.
16. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2007;30(suppl 1):S42-S47. doi: 10.2337/ dc10-S062.
17. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ; Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440-1463. doi: 10.1016/j.echo.2005.10.005.
18. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57:450-458. doi: 10.1016/0002-9149(86)90771-X.
19. Marwick TH, Gillebert TC, Aurigemma G, Chirinos J, Derumeaux G, Galderisi M, Gottdiener J, Haluska B, Ofili E, Segers P, Senior R, Tapp RJ, Zamorano JL. Recommendations on the use of echocardiography in adult hypertension: a report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE)†. Eur Heart J Cardiovasc Imaging. 2015;16:577-605. doi: 10.1093/ehjci/jev076.
20. Izzo R, de Simone G, Chinali M, Iaccarino G, Trimarco V, Rozza F, Giudice R, Trimarco B, De Luca N. Insufficient control of blood pressure and incident diabetes. Diabetes Care. 2009;32:845-850. doi: 10.2337/dc08-1881.
21. Barnard J, Meng XL. Applications of multiple imputation in medical studies: from AIDS to NHANES. Stat Methods Med Res. 1999;8:17-36. doi: 10.1177/096228029900800103.
22. Verdecchia P, Palatini P, Schillaci G, Mormino P, Porcellati C, Pessina AC. Independent predictors of isolated clinic ('whitecoat') hypertension. J Hypertens. 2001;19:1015-1020. doi: 10.1097/00004872-200106000-00004.
23. Gidding SS, Liu K, Colangelo LA, Cook NL, Goff DC, Glasser SP, Gardin JM, Lima JA. Longitudinal determinants of left ventricular mass and geometry: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Circ Cardiovasc Imaging. 2013;6:769-775. doi: 10.1161/CIRCIMAGING.112.000450.
24. Verdecchia P, Sleight P, Mancia G, Fagard R, Trimarco B, Schmieder RE, Kim JH, Jennings G, Jansky P, Chen JH, Liu L, Gao P, Probstfield J, Teo K, Yusuf S; ONTARGET/TRANSCEND Investigators. Effects of telmisartan, ramipril, and their combination on left ventricular hypertrophy in individuals at high vascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial and the Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease. Circulation. 2009;120:1380-1389. doi: 10.1161/CIRCULATIONAHA.109.865774.
25. De Marco M, de Simone G, Izzo R, Mancusi C, Sforza A, Giudice R, Trimarco B, De Luca N. Classes of antihypertensive medications and blood pressure control in relation to metabolic risk factors. J Hypertens. 2012;30:188-193. doi: 10.1097/HJH.0b013e32834e1eda.
26. Esposito R, Izzo R, Galderisi M, De Marco M, Stabile E, Esposito G, Trimarco V, Rozza F, De Luca N, de Simone G. Identification of phenotypes at risk of transition from diastolic hypertension to isolated systolic hypertension. J Hum Hypertens. 2016;30:392-396. doi: 10.1038/ jhh.2015.91.
27. de Simone G, Devereux RB, Izzo R, Girfoglio D, Lee ET, Howard BV, Roman MJ. Lack of reduction of left ventricular mass in treated hypertension: the strong heart study. J Am Heart Assoc. 2013;2:e000144. doi: 10.1161/JAHA.113.000144.
28. de Simone G, Izzo R, De Luca N, Gerdts E. Left ventricular geometry in obesity: Is it what we expect? Nutr Metab Cardiovasc Dis. 2013;23:905-912. doi: 10.1016/j.numecd.2013.06.012.
29. Palatini P, Saladini F, Mos L, Benetti E, Bortolazzi A, Cozzio S, Casiglia E. Obesity is a strong determinant of hypertensive target organ damage in young-to-middle-age patients. Int J Obes. 2013;37:224-229. doi: 10.1038/ijo.2012.32.
30. Cuspidi C, Rescaldani M, Tadic M, Sala C, Grassi G. Effects of bariatric surgery on cardiac structure and function: a systematic review and metaanalysis. Am J Hypertens. 2014;27:146-156. doi: 10.1093/ajh/hpt215.
31. Damiano S, De Marco M, Del Genio F, Contaldo F, Gerdts E, de Simone G, Pasanisi F. Effect of bariatric surgery on left ventricular geometry and function in severe obesity. Obes Res Clin Pract. 2012;6:e175-e262. doi: 10.1016/j.orcp.2012.02.008.
32. Al-Daydamony MM, El-Tahlawi M. What is the effect of metabolic syndrome without hypertension on left ventricular hypertrophy? Echocardiography. 2016;33:1284-1289. doi: 10.1111/echo.13247.
33. Wadden TA, Webb VL, Moran CH, Bailer BA. Lifestyle modification for obesity: new developments in diet, physical activity, and behavior therapy. Circulation. 2012;125:1157-1170. doi: 10.1161/ CIRCULATIONAHA.111.039453.
34. Gerdts E, Zabalgoitia M, Björnstad H, Svendsen TL, Devereux RB. Gender differences in systolic left ventricular function in hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE study). Am J Cardiol. 2001;87:980-983;A984.
35. Devereux RB, Bella JN, Palmieri V, Oberman A, Kitzman DW, Hopkins PN, Rao DC, Morgan D, Paranicas M, Fishman D, Arnett DK; Hypertension Genetic Epidemiology Network Study Group. Left ventricular systolic dysfunction in a biracial sample of hypertensive adults: The Hypertension Genetic Epidemiology Network (HyperGEN) Study. Hypertension. 2001;38:417-423. doi: 10.1161/01.HYP.38.3.417.
36. Gerdts E, Okin PM, de Simone G, Cramariuc D, Wachtell K, Boman K, Devereux RB. Gender differences in left ventricular structure and function during antihypertensive treatment: the Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension. 2008;51:1109-1114. doi: 10.1161/HYPERTENSIONAHA.107.107474.
37. De Simone G, Devereux RB, Chinali M, Roman MJ, Barac A, Panza JA, Lee ET, Howard BV. Sex differences in obesity-related changes in left ventricular morphology: the Strong Heart Study. J Hypertens. 2011;29:1431-1438. doi: 10.1097/HJH.0b013e328347a093.
38. Sharma K, Kass DA. Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapies. Circ Res. 2014;115:79-96. doi: 10.1161/CIRCRESAHA.115.302922.
39. Okin PM, Devereux RB, Harris KE, Jern S, Kjeldsen SE, Julius S, Edelman JM, Dahlöf B; LIFE Study Investigators. Regression of electrocardiographic left ventricular hypertrophy is associated with less hospitalization for heart failure in hypertensive patients. Ann Intern Med. 2007;147:311-319. doi: 10.7326/0003-4819-147-5-200709040-00006.
40. Devereux RB Alderman MH. Role of preclinical cardiovascular disease in the evolution from risk factor exposure to development of morbid events. Circulation. 1993;88(4 pt 1):1444-1455. doi: 10.1161/01. CIR.88.4.1444.
41. Lam CS, Shah AM, Borlaug BA, Cheng S, Verma A, Izzo J, Oparil S, Aurigemma GP, Thomas JD, Pitt B, Zile MR, Solomon SD. Effect of antihypertensive therapy on ventricular-arterial mechanics, coupling, and efficiency. Eur Heart J. 2013;34:676-683. doi: 10.1093/eurheartj/ ehs299.